NOCAUTE DO GENE BETA-2 MICROGLOBULINA EM CÉLULAS DERIVADAS DO TECIDO ADIPOSO UTILIZANDO O SISTEMA CRISPR/CAS9 PARA A GERAÇÃO DE PLAQUETAS HLA CLASSE I UNIVERSAIS

Autor: LF Catelli, MAF Corat, FS Niemann, AS Santos, NG Amôr, IPF Santos, FBS Teófilo, PSD Santos, STO Saad

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S757-S758 (2023)

A refratariedade é um problema recorrente no tratamento de pacientes trombocitopênicos que impede a restauração dos níveis normais de plaquetas circulantes após transfusões. Sua principal causa é a incompatibilidade entre os antígenos HLA Cl

Externí odkaz: https://doaj.org/article/b9cf0f2b1b63497e847d4c988c05120a

Frequency and characterization of RHD variant alleles in a population of blood donors from southeastern Brazil: Comparison with other populations.

Autor: Rodrigues ES; Center for Cell-Based Research, Regional Blood Center of Ribeirão Preto, School of Medicine of Ribeirão Preto, São Paulo, Brazil; University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil. Electronic address: evandra@hemocentro.fmrp.usp.br., Romagnoli AC; Center for Cell-Based Research, Regional Blood Center of Ribeirão Preto, School of Medicine of Ribeirão Preto, São Paulo, Brazil; University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil., Santos FLS; Center for Cell-Based Research, Regional Blood Center of Ribeirão Preto, School of Medicine of Ribeirão Preto, São Paulo, Brazil; University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil., Cutter TB; Center for Cell-Based Research, Regional Blood Center of Ribeirão Preto, School of Medicine of Ribeirão Preto, São Paulo, Brazil; University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil., Catelli LF; Center for Cell-Based Research, Regional Blood Center of Ribeirão Preto, School of Medicine of Ribeirão Preto, São Paulo, Brazil; University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil., Cédric V; Département Centre National de Référence pour les Groupes Sanguins, Institut National de la Transfusion Sanguine (INTS), Paris, France., Peyrard T; Département Centre National de Référence pour les Groupes Sanguins, Institut National de la Transfusion Sanguine (INTS), Paris, France., Covas DT; Center for Cell-Based Research, Regional Blood Center of Ribeirão Preto, School of Medicine of Ribeirão Preto, São Paulo, Brazil; University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil; Department of Clinical Medicine, School of Medicine of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil., de Castilho LM; Laboratório de Imunohematologia Molecular do Hemocentro - Unicamp, Campinas, SP, Brazil., Kashima S; Center for Cell-Based Research, Regional Blood Center of Ribeirão Preto, School of Medicine of Ribeirão Preto, São Paulo, Brazil; University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil.

Publikováno v: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2021 Aug; Vol. 60 (4), pp. 103135. Date of Electronic Publication: 2021 Apr 08.

Generation of integration-free induced pluripotent stem cells from blood-derived cells isolated from patient with severe haemophilia A.

Autor: Ferreira AF; Center for Cell based Therapy, Regional Blood Center, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil., Ferreira FU; Center for Cell based Therapy, Regional Blood Center, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil., Costa PNMD; Center for Cell based Therapy, Regional Blood Center, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil., Catelli LF; Center for Cell based Therapy, Regional Blood Center, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil., Favarin Macedo MDC; Center for Cell based Therapy, Regional Blood Center, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil., Santos TPMD; School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil., Leopoldino AM; School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil., Picanço-Castro V; Center for Cell based Therapy, Regional Blood Center, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil., Kashima S; Center for Cell based Therapy, Regional Blood Center, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.; School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil., Covas DT; Center for Cell based Therapy, Regional Blood Center, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.

Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2019 May; Vol. 25 (3), pp. e195-e199. Date of Electronic Publication: 2019 Mar 13.